The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis - a pilot study.

Martin, C R; Blanco, P G; Keach, J C; Petz, J L; Zaman, M M; Bhaskar, K R; Cluette-Brown, J E; Gautam, S; Sheth, S; Afdhal, N H; Lindor, K D; Freedman, S D

Martin, C R; Blanco, P G; Keach, J C; Petz, J L; Zaman, M M; Bhaskar, K R; Cluette-Brown, J E; Gautam, S; Sheth, S; Afdhal, N H; Lindor, K D; Freedman, S D.

Affiliation

Martin CR; Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.

Aliment Pharmacol Ther ; 35(2): 255-65, 2012 Jan.

Article in En | MEDLINE | ID: mdl-22129201

Subject(s)

Bile Ducts/drug effects; Cholangitis, Sclerosing/drug therapy; Dietary Supplements/adverse effects; Docosahexaenoic Acids/administration & dosage; Liver/drug effects; Administration, Oral; Adult; Alkaline Phosphatase/metabolism; Biomarkers/metabolism; Docosahexaenoic Acids/adverse effects; Female; Humans; Liver Function Tests; Male; Middle Aged; Pilot Projects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Ducts / Cholangitis, Sclerosing / Docosahexaenoic Acids / Dietary Supplements / Liver Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Aliment Pharmacol Ther Year: 2012 Document type: Article

Fulltext

XML

PubMed Links

Search on Google